The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristicsDavid C. Wheeler, Hiddo J.L. Heerspink, М. М. Батюшин et al.|Nephrology Dialysis Transplantation|2020Cited by 189
PKCβ modulates antigen receptor signaling via regulation of Btk membrane localizationShin‐Wook Kang, David J. Rawlings|The EMBO Journal|2001Cited by 148